Clinical, Oncological and Metabolic Effects of Pancreatic Mass Loss After Partial, Near-total and Total Pancreatectomy in Patients With Preoperative Diabetes Mellitus

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

This study will examine how removal of part or all of the pancreas affects blood sugar control, metabolism, and clinical outcomes over time.

The study will include adults with diabetes before surgery who undergo pancreatic surgery as part of routine clinical care at Fondazione Policlinico Universitario A. Gemelli IRCCS.

Researchers will study whether glycemic control worsens after surgery and whether this risk changes according to the type of pancreatic resection. The study will also examine changes in glucose metabolism, and cancer-related outcomes.

Information from routine clinical care, metabolic tests, imaging, and pancreatic tissue samples collected during surgery may be used for research analyses.

Eligibility criteria

Qualifiers

Adult patients (≥18 years)

Diabetes mellitus at baseline

Undergoing partial, near-total, or total pancreatectomy at the study center for benign or malignant pancreatic disease

Availability of clinical and metabolic follow-up data according to study component

Disqualifiers

Age <18 years

Absence of diabetes mellitus at baseline

Missing essential clinical data or incomplete follow-up precluding evaluation of study outcomes

Severe pre-existing non-oncologic clinical conditions with life expectancy <6 months

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

408 Participants
are grouped into 3 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

European Foundation for the Study of Diabetes

Collaborator